News of the Nordic SBRT-study group
Presentations at international and national conferences 2024
ESTRO 2024
Karlsson K, Rancati T, Lindberg S, Grozman V, Hoffmann L, Khalil A, Marquard Knap M, Bj酶rn Nielsen T, Starup Jeppesen S, Kristiansen C, Ramberg C, Rogg Lotte V, Drugge N, Nyman J, Josipovic M, Fredberg Persson G, Olofsson J, Bergstr枚m P, Rosenbrand H-O, L枚d茅n B, Haraldsson A, Engelholm S, Billiet Charlotte, MD, Lindberg K, Onjukka E. Cox-based prediction model of grade 5 bleeding after SBRT of ultra-centrally located lung tumors. Presenteras 4:e maj 2024 p氓 sessionen: 鈥漃roffered Paper - Radiomics, dose analysis and outcome prediction鈥
Susanne N酶rring Bekke, Susan Blak Nyrup Biancardo, Kristian Boye, C茅cile Peucelle, Anders Smedegaard Bertelsen, Lone Hoffmann, Tine Schytte, Mette P酶hl, Gitte Persson Daily adaptive MR-guided SBRT of ultra-central lung tumors (NCT05354596) 鈥 first dosimetric results.
Publikations in scientific journals
van Overeem Felter M, M酶ller PK, Josipovic M, Bekke SN, Bernchou U, Serup-Hansen E, Madsen K, Parikh PJ, Kim J, Geertsen P, Behrens CP, Vogelius IR, P酶hl M, Schytte T, Persson GF
Radiother Oncol 2024 Mar;192():110090
Onjukka E, Karlsson K, Lindberg K
Int J Radiat Oncol Biol Phys 2024 Mar;118(4):1144
Lindberg S, Grozman V, Karlsson K, Onjukka E, Lindb盲ck E, Jirf KA, Lax I, Wers盲ll P, Persson GF, Josipovic M, Khalil AA, M酶ller DS, Hoffmann L, Knap MM, Nyman J, Drugge N, Bergstr枚m P, Olofsson J, Rogg LV, Hagen RK, Fr酶land AS, Ramberg C, Kristiansen C, Jeppesen SS, Nielsen TB, L枚d茅n B, Rosenbrand HO, Engelholm S, Haraldsson A, Billiet C, Lewensohn R, Lindberg K
Int J Radiat Oncol Biol Phys 2023 Dec;117(5):1222-1231
Lindberg S, Onjukka E, Wers盲ll P, Staff C, Lewensohn R, Masucci G, Lindberg K
Clin Transl Radiat Oncol 2022 Sep;36():91-98
Hoffmann L, Persson GF, Nyg氓rd L, Nielsen TB, Borrisova S, Gaard-Petersen F, Josipovic M, Khalil AA, Kjeldsen R, Knap MM, Kristiansen C, M酶ller DS, Ottosson W, Sand H, Thing R, P酶hl M, Schytte T
Radiother Oncol 2022 Jun;171():53-61
Lindberg K, Onjukka E
J Radiol Prot 2021 Nov;41(4):
Karlsson K, Lax I, Lindb盲ck E, Grozman V, Lindberg K, Wers盲ll P, Poludniowski G
Phys Med 2021 Aug;88():53-64
Lindberg K, Grozman V, Karlsson K, Lindberg S, Lax I, Wers盲ll P, Persson GF, Josipovic M, Khalil AA, Moeller DS, Nyman J, Drugge N, Bergstr枚m P, Olofsson J, Rogg LV, Ramberg C, Kristiansen C, Jeppesen SS, Nielsen TB, L枚d茅n B, Rosenbrand HO, Engelholm S, Haraldsson A, Billiet C, Lewensohn R
J Thorac Oncol 2021 Jul;16(7):1200-1210
Grozman V, Onjukka E, Wers盲ll P, Lax I, Tsakonas G, Nyren S, Lewensohn R, Lindberg K
Acta Oncol 2021 Mar;60(3):305-311
Lindberg K, Grozman V, Lindberg S, Onjukka E, Lax I, Lewensohn R, Wers盲ll P
Acta Oncol 2019 Aug;58(8):1178-1186
Lindberg K, Nyman J, Riesenfeld K盲llskog V, Hoyer M, Lund J脜, Lax I, Wers盲ll P, Karlsson K, Friesland S, Lewensohn R
Acta Oncol 2015 ;54(8):1096-104
Peulen H, Karlsson K, Lindberg K, Tullgren O, Baumann P, Lax I, Lewensohn R, Wers盲ll P
Radiother Oncol 2011 Nov;101(2):260-6
Nyman J, Hallqvist A, Lund J脜, Brustugun OT, Bergman B, Bergstr枚m P, Friesland S, Lewensohn R, Holmberg E, Lax I
Radiother Oncol 2016 Oct;121(1):1-8
Presentations in international och national conferences (2021-2023)
ESTRO 2023
Lindb盲ck E, Al Jirf K, Hoffman L, Sloth Moeller D, Karlsson K, Nyberg Thomsen S, Lindberg K, Ahmed Khalil A, Uzan J, Onjukka E. SBRT for central lung lesions: large biological delivered dose deviations for the bronchi
ESTRO 2022
Hoffmann L, Persson GF, Nyg氓rd L, Nielsen TB, Borrisova S, Gaard-Petersen F, Josipovic M, Khalil AA, Kjeldsen R, Knap MM, Kristiansen C, M酶ller DS, Ottosson W, Sand H, Thing R, P酶hl M & Schytte T. Pre-study QA reduces delineation errors and minimize dose to OAR in a central lung tumour SBRT trial.
Swedish National meeting of Radiation Therapy 2023
Oral presentation of Stereotactic radiation therapy of central lung tumours - the HILUS-studies"
ELCC 2021
Hallqvist A, Koyi H, dePetris L, Lindberg K, Farooqi S, Helland 脜, Wikstrom A, Johansson M, Planck M, Lindberg L, Yksn酶y O, Gr酶nberg B.H, Helbekkmo N, Nyman J. Safety analysis of durvalumab following stereotactic body radiotherapy (SBRT) in early-stage non-small cell lung cancer (NSCLC) patients: A first report of a randomized phase II trial (ASTEROID). Journal of Thoracic Oncology Vol.16No.4S:S729鈥揝736, 63MO. (L盲nk:
Organisations and companies supporting the work and studies of the Nordic SBRT-study group
The followint organizations and companies have contributed with financial support which has enabled the work of the group and the studies conducted within the group. The support has also enabled the group to expand through the education of clinically active PhD-students.
- The Swedish Cancer Society
- The Funds of Radiumhemmet
- Nordforsk
- Amgen
- The funds of 探花精选
- The Swedish Society of Medicine
- Stockholm County Council (ALF-funds)
- Varian Medical Systems
- Villadsens Family Foundation
- The Danish Cancer Society
- Independant Researh Foundation Denmark
- The Danish National Research Center for Radiotherapy, Danish Cancer Society and Danish Comprehensive Cancer Center.